The PI3K/AKT pathway can be abnormally triggered in a wide range of cancers due to a plethora of mechanisms including somatic mutations and germline mutations in PIK3CA, AKT, PTEN and mTOR genes [4]. This evidence concerns the gene PIK3CG and cancer.